Table 3 Characteristics of women living with HIV (WLWH) in a referral hospital in Tehran, Iran, March 2023–2024

Age (years)

Immune

39.50 ± 3.62

38.57 ± 6.33

38.40 ± 5.29

39.00 ± 2.83

Non-Immune

37.55 ± 6.16

37.22 ± 5.70

34.69 ± 7.98

37.73 ± 6.02

P Value

0.385

0.341

0.04

0.767

First CD4^*(cells/mm³)

Immune

567.00 ± 196.79

434.57 ± 297.92

410.84 ± 290.96

682.00 ± 77.78

Non-Immune

370.94 ± 284.46

363.38 ± 270.56

301.31 ± 222.30

383.90 ± 281.54

P Value

0.063

0.287

0.205

0.141

Last CD4 (cells/mm³)

Immune

731.88 ± 318.00

773.23 ± 360.99

735.15 ± 343.79

997.50 ± 60.10

Non-Immune

717.73 ± 341.88

683.24 ± 319.76

643.38 ± 305.95

711.62 ± 338.72

P Value

0.917

0.261

0.793

0.240

CD4 NADIR (cells/mm³)

Immune

450.57 ± 268.68

311.07 ± 211.58

296.27 ± 218.83

429.00

Non-Immune

259.00 ± 203.31

255.07 ± 218.37

193.00 ± 186.98

275.49 ± 216.71

P Value

0.025

0.284

0.119

0.484

HIV^* duration (years)

Immune

3039.25 ± 2390.46

3235.31 ± 1779.80

2908.98 ± 1910.48

4940.50 ± 2595.79

Non-Immune

2963.52 ± 1873.80

2801.82 ± 2001.46

3266.00 ± 1997.98

2917.01 ± 1889.78

P Value

0.917

0.346

0.546

0.142